Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies

American Journal of Hypertension

Volumn 25, Issue 6, 2012, Pages 711-717

  Wu, Yuquan ^a   Xiong, Xu ^b   Fraser, William D ^a   Luo, Zhong Cheng ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b TULANE UNIVERSITY   (United States)

Author keywords

Adverse conditions; blood pressure; gestational hypertension; hypertension; preeclampsia; progression; uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URIC ACID BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL-FETAL RELATIONS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; URIC ACID;

EID: 84862801206     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2012.18     Document Type: Article

References (29)

1. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46:1243-1249. (Pubitemid 43189714)
2. Barton JR, O'brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001; 184:979-983. (Pubitemid 32368119)
3. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998; 105:1177-1184. (Pubitemid 28526200)
4. Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 2011; 58:704-708.
5. Davis GK, Mackenzie C, Brown MA, Homer CS, Holt J, McHugh L, Mangos G. Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertens Pregnancy 2007; 26:77-87. (Pubitemid 46649345)
6. ACOG Committee on Practice Bulletin-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99:159-167.
7. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, Blondel B, Bréart G; Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108:E35.
8. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001; 344:467-471. (Pubitemid 32164897)
9. Dietz PM, England LJ, Callaghan WM, Pearl M, Wier ML, Kharrazi M. A comparison of LMP-based and ultrasound-based estimates of gestational age using linked California livebirth and prenatal screening records. Paediatr Perinat Epidemiol 2007; 21 Suppl 2:62-71. (Pubitemid 47347808)
10. Lind T, Godfrey KA, Otun H, Philips PR. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984; 91:128-132. (Pubitemid 14181944)
11. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330:565.
12. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112:359-372.
13. Redman CW, Williams GF, Jones DD, Wilkinson RH. Plasma urate and serum deoxycytidylate deaminase measurements for the early diagnosis of preeclampsia. Br J Obstet Gynaecol 1977; 84:904-908. (Pubitemid 8251572)
14. MasséJ, Forest JC, Moutquin JM, Marcoux S, Brideau NA, Bélanger M. A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. Am J Obstet Gynecol 1993; 169:501-508. (Pubitemid 23290155)
15. Wolak T, Sergienko R, Wiznitzer A, Paran E, Sheiner E. High Uric Acid Level During the First 20 Weeks of Pregnancy is Associated with Higher Risk for Gestational Diabetes Mellitus and Mild Preeclampsia. Hypertens Pregnancy 2010.
16. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187:127-136. (Pubitemid 34800311)
17. Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol 2009; 146:8-14.
18. Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS; Tests in Prediction of Pre-eclampsia Severity review group. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 2006; 113:369-378.
19. Laughon SK, Catov J, Powers RW, Roberts JM, Gandley RE. First trimester uric acid and adverse pregnancy outcomes. Am J Hypertens 2011; 24:489-495.
20. Hander JS. The role of lactic acid in the reduced excretion of uric acid in toxemia of pregnancy. J Clin Invest 1960; 39:1526-1532.
21. Bainbridge SA, Roberts JM, von Versen-Höynck F, Koch J, Edmunds L, Hubel CA. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol, Cell Physiol 2009; 297:C440-C450.
22. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46:1263-1269. (Pubitemid 43189721)
23. Koopmans CM, Zwart JJ, Groen H, Bloemenkamp KW, Mol BW, Van Pampus MG, Van Roosmalen J. Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term. Hypertens Pregnancy 2011; 30:433-446.
24. Bainbridge SA, von Versen-Höynck F, Roberts JM. Uric acid inhibits placental system A amino acid uptake. Placenta 2009; 30:195-200.
25. Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008; 21:1343-1346.
26. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29 Suppl A:S67-S72.
27. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53:812-818.
28. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683. (Pubitemid 38364626)
29. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355:992-1005. (Pubitemid 44343543)